Source:http://linkedlifedata.com/resource/pubmed/id/21444764
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2011-4-20
|
pubmed:abstractText |
Cigarette smoking is a significant environmental factor in the human inflammatory bowel diseases, remarkably, conferring protection in ulcerative colitis. We previously demonstrated that a prominent component of cigarette smoke, CO, suppresses Th17-mediated experimental colitis in IL-10(-/-) mice through a heme oxygenase (HO)-1-dependent pathway. In this study, homeostatic and therapeutic effects of CO and HO-1 were determined in chronic colonic inflammation in TCR-?-deficient ((-/-)) mice, in which colitis is mediated by Th2 cytokines, similar to the cytokine milieu described in human ulcerative colitis. TCR?(-/-) mice exposed to CO or treated with the pharmacologic HO-1 inducer cobalt protoporphyrin demonstrated amelioration of active colitis. CO and cobalt protoporphyrin suppressed colonic IL-1?, TNF, and IL-4 production, whereas IL-10 protein secretion was increased. CO induced IL-10 expression in macrophages and in vivo through an HO-1-dependent pathway. Bacterial products regulate HO-1 expression in macrophages through MyD88- and IL-10-dependent pathways. CO exposure and pharmacologic HO-1 induction in vivo resulted in increased expression of HO-1 and IL-10 in CD11b(+) lamina propria mononuclear cells. Moreover, induction of the IL-10 family member IL-22 was demonstrated in CD11b(-) lamina propria mononuclear cells. In conclusion, CO and HO-1 induction ameliorated active colitis in TCR?(-/-) mice, and therapeutic effects correlated with induction of IL-10. This study provides further evidence that HO-1 mediates an important homeostatic pathway with pleiotropic anti-inflammatory effects in different experimental models of colitis and that targeting HO-1, therefore, is a potential therapeutic strategy in human inflammatory bowel diseases.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/F32 DK083186,
http://linkedlifedata.com/resource/pubmed/grant/F32 DK083186-01,
http://linkedlifedata.com/resource/pubmed/grant/F32 DK083186-02,
http://linkedlifedata.com/resource/pubmed/grant/P30 DK034987,
http://linkedlifedata.com/resource/pubmed/grant/R01 DK054452-09,
http://linkedlifedata.com/resource/pubmed/grant/R01 DK54452,
http://linkedlifedata.com/resource/pubmed/grant/T32 DK007737
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1550-6606
|
pubmed:author |
pubmed-author:HegaziRefaat ARA,
pubmed-author:KobayashiTakuT,
pubmed-author:LiFenglingF,
pubmed-author:MatsuokaKatsuyoshiK,
pubmed-author:OnyiahJoseph CJC,
pubmed-author:OtterbeinLeo ELE,
pubmed-author:PlevyScott ESE,
pubmed-author:RussoSteven MSM,
pubmed-author:SepulvedaAntonia RAR,
pubmed-author:SheikhShehzad ZSZ
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
186
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5506-13
|
pubmed:dateRevised |
2011-10-19
|
pubmed:meshHeading |
pubmed-meshheading:21444764-Animals,
pubmed-meshheading:21444764-Blotting, Western,
pubmed-meshheading:21444764-Carbon Monoxide,
pubmed-meshheading:21444764-Cell Separation,
pubmed-meshheading:21444764-Colitis,
pubmed-meshheading:21444764-Cytokines,
pubmed-meshheading:21444764-Disease Models, Animal,
pubmed-meshheading:21444764-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21444764-Flow Cytometry,
pubmed-meshheading:21444764-Heme Oxygenase-1,
pubmed-meshheading:21444764-Interleukin-10,
pubmed-meshheading:21444764-Macrophages,
pubmed-meshheading:21444764-Mice,
pubmed-meshheading:21444764-Mice, Knockout,
pubmed-meshheading:21444764-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21444764-Th2 Cells
|
pubmed:year |
2011
|
pubmed:articleTitle |
An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis.
|
pubmed:affiliation |
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|